title: Nutritional status in patients with diabetes and chronic kidney disease: a prospective study.
abstract: BACKGROUND
  A poor nutritional status reduces the life expectancy of diabetes patients undergoing hemodialysis.
  
  
  OBJECTIVE
  The study objective was to specify the nutritional outcome in patients with chronic kidney disease (CKD) and well-controlled diabetes.
  
  
  METHODS
  Forty-five diabetes patients with CKD were enrolled in a cooperative-care program designed to control glucose, blood pressure, LDL cholesterol, and the albumin excretion rate (AER). Their glomerular filtration rate (GFR), body composition, serum albumin (SA), and resting energy expenditure were assessed and compared at baseline and 2 y later.
  
  
  RESULTS
  Thirty-five patients did not start dialysis. Their glycated hemoglobin, blood pressure, LDL cholesterol, and AER improved; their GFR declined slowly (-3.3 mL x min(-1) x 1.73 m(-2) x y(-1)). Their body mass index (BMI), lean body mass, and SA increased. The GFR decline was correlated negatively with the initial BMI (r = -0.37, P < 0.05) and positively with the initial GFR (r = 0.34, P < 0.05). Ten patients started hemodialysis: except for higher total body water (P < 0.05) and extracellular volume (P < 0.01), their initial nutritional status did not differ significantly from that of 10 patients with comparable baseline severe CKD but without dialysis. At the second evaluation, patients on hemodialysis lost lean body mass, and their SA was lower than that of the patients with severe CKD (P = 0.05); lean body mass was unchanged and SA was higher (P = 0.01) in the patients with severe CKD. No significant difference was detected for resting energy expenditure.
  
  
  CONCLUSIONS
  Nutritional status improved in CKD patients with well-controlled diabetes without dialysis, and it deteriorated in patients who started dialysis. A high initial BMI was associated with a slower decline in GFR.
authors.affiliation: Department of Nutrition-Diabetology, Université Victor Segalen-Bordeaux 2 and Centre Hospitalier de Bordeaux, Bordeaux, France. christelleraf@yahoo.fr
authors.forename: Christelle
authors.initials: C
authors.lastname: Raffaitin
authors.forename: Catherine
authors.initials: C
authors.lastname: Lasseur
authors.forename: Philippe
authors.initials: P
authors.lastname: Chauveau
authors.forename: Nicole
authors.initials: N
authors.lastname: Barthe
authors.forename: Henri
authors.initials: H
authors.lastname: Gin
authors.forename: Christian
authors.initials: C
authors.lastname: Combe
authors.forename: Vincent
authors.initials: V
authors.lastname: Rigalleau
mesh_terms: D000368:Aged; D001481:Basal Metabolism / Q000502:physiology*; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000502:physiology; D001823:Body Composition / Q000502:physiology; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000502:physiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000628:therapy; D008017:Life Expectancy; D008297:Male; D009752:Nutritional Status; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects; D012709:Serum Albumin / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D012709:Serum Albumin; D002784:Cholesterol